Diabetes mellitus is a strong negative prognostic factor in patients with myocardial infarction treated with thrombolytic therapy.
Open Access
- 1 August 2000
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 248 (2) , 119-125
- https://doi.org/10.1046/j.1365-2796.2000.00007.x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Arterial structural modifications in hypertension. effects of treatmentPublished by Elsevier ,1997
- Clinical benefit of angiotensin converting enzyme inhibition after acute myocardial infarctionJournal Of Hypertension, 1996
- Outcomes of diabetic patients following acute myocardial infarctionCoronary Artery Disease, 1996
- Vectorcardiographic monitoring to assess early vessel patency after reperfusion therapy for acute myocardial infarctionEuropean Heart Journal, 1995
- Prognostic information from on-line vectorcardiography in acute myocardial infarctionThe American Journal of Cardiology, 1994
- Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 1989
- Factors leading to shorter survival after acute myocardial infarction in patients ages 65 to 75 years compared with younger patientsThe American Journal of Cardiology, 1988
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Books ReceivedNew England Journal of Medicine, 1983
- Evaluation of methods for quantitating left ventricular segmental wall motion in man using myocardial markers as a standard.Circulation, 1980